 |  | |
S5004
Managing HIV/AIDS Therapy in Special Populations:
Salvage Therapy Case Study
Case Presentation: Michael Wohlfeiler, MD, JD
As a good candidate, the patient enrolled in the tipranavir RESIST trial. He would receive tipranavir 500 mg BID boosted with ritonavir 200 mg BID. The investigator had to select an "optimized background therapy."
Which "optimized background therapy" would you select?
|
|
 Go Back |
Exit Case  |